Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Infect Dis ; 73(2): e345-e354, 2021 07 15.
Article in English | MEDLINE | ID: mdl-32615591

ABSTRACT

BACKGROUND: Death in patients with chikungunya is rare and has been associated with encephalitis, hemorrhage, and septic shock. We describe clinical, histologic, and immunohistochemical findings in individuals who died following chikungunya virus (CHIKV) infection. METHODS: We identified individuals who died in Puerto Rico during 2014 following an acute illness and had CHIKV RNA detected by reverse transcriptase-polymerase chain reaction in a pre- or postmortem blood or tissue specimen. We performed histopathology and immunohistochemistry (IHC) for CHIKV antigen on tissue specimens and collected medical data via record review and family interviews. RESULTS: Thirty CHIKV-infected fatal cases were identified (0.8/100 000 population). The median age was 61 years (range: 6 days-86 years), and 19 (63%) were male. Death occurred a median of 4 days (range: 1-29) after illness onset. Nearly all (93%) had at least 1 comorbidity, most frequently hypertension, diabetes, or obesity. Nine had severe comorbidities (eg, chronic heart or kidney disease, sickle cell anemia) or coinfection (eg, leptospirosis). Among 24 fatal cases with tissue specimens, 11 (46%) were positive by IHC. CHIKV antigen was most frequently detected in mesenchymal tissues and mononuclear cells including tissue macrophages, blood mononuclear cells, splenic follicular dendritic cells, and Kupffer cells. Common histopathologic findings were intra-alveolar hemorrhage and edema in the lung, chronic or acute tenosynovitis, and increased immunoblasts in the spleen. CHIKV infection likely caused fatal septic shock in 2 patients. CONCLUSIONS: Evaluation of tissue specimens provided insights into the pathogenesis of CHIKV, which may rarely result in septic shock and other severe manifestations.


Subject(s)
Chikungunya Fever , Chikungunya virus , Diabetes Mellitus , Chikungunya Fever/complications , Chikungunya Fever/epidemiology , Comorbidity , Humans , Male , Middle Aged , Puerto Rico
2.
MMWR Morb Mortal Wkly Rep ; 65(52): 1474-1476, 2017 Jan 06.
Article in English | MEDLINE | ID: mdl-28056006

ABSTRACT

On December 1, 2015, the Puerto Rico Department of Health (PRDH) was notified by a local hospital of a suspected human rabies case. The previous evening, a Puerto Rican man aged 54 years arrived at the emergency department with fever, difficulty swallowing, hand paresthesia, cough, and chest tightness. The next morning the patient left against medical advice but returned to the emergency department in the afternoon with worsening symptoms. The patient's wife reported that he had been bitten by a mongoose during the first week of October, but had not sought care for the bite. While being transferred to the intensive care unit, the patient went into cardiac arrest and died. On December 3, rabies was confirmed from specimens collected during autopsy. PRDH conducted an initial rapid risk assessment, and five family members were started on rabies postexposure prophylaxis (PEP).


Subject(s)
Bites and Stings , Herpestidae/virology , Rabies virus/isolation & purification , Rabies/diagnosis , Rabies/transmission , Animals , Contact Tracing , Fatal Outcome , Humans , Male , Middle Aged , Post-Exposure Prophylaxis , Puerto Rico , Rabies/prevention & control
3.
PLoS Negl Trop Dis ; 10(10): e0005025, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27727271

ABSTRACT

BACKGROUND: Dengue is a leading cause of morbidity throughout the tropics; however, accurate population-based estimates of mortality rates are not available. METHODS/PRINCIPAL FINDINGS: We established the Enhanced Fatal Acute Febrile Illness Surveillance System (EFASS) to estimate dengue mortality rates in Puerto Rico. Healthcare professionals submitted serum and tissue specimens from patients who died from a dengue-like acute febrile illness, and death certificates were reviewed to identify additional cases. Specimens were tested for markers of dengue virus (DENV) infection by molecular, immunologic, and immunohistochemical methods, and were also tested for West Nile virus, Leptospira spp., and other pathogens based on histopathologic findings. Medical records were reviewed and clinical data abstracted. A total of 311 deaths were identified, of which 58 (19%) were DENV laboratory-positive. Dengue mortality rates were 1.05 per 100,000 population in 2010, 0.16 in 2011 and 0.36 in 2012. Dengue mortality was highest among adults 19-64 years and seniors ≥65 years (1.17 and 1.66 deaths per 100,000, respectively). Other pathogens identified included 34 Leptospira spp. cases and one case of Burkholderia pseudomallei and Neisseria meningitidis. CONCLUSIONS/SIGNIFICANCE: EFASS showed that dengue mortality rates among adults were higher than reported for influenza, and identified a leptospirosis outbreak and index cases of melioidosis and meningitis.


Subject(s)
Dengue/mortality , Disease Outbreaks/statistics & numerical data , Epidemiological Monitoring , Acute Disease/epidemiology , Adolescent , Adult , Coinfection/epidemiology , Dengue/epidemiology , Dengue/virology , Dengue Virus/genetics , Dengue Virus/immunology , Dengue Virus/isolation & purification , Female , Humans , Leptospira/genetics , Leptospira/immunology , Leptospirosis/epidemiology , Leptospirosis/microbiology , Male , Medical Records , Middle Aged , Mortality , Puerto Rico/epidemiology , Time Factors , West Nile virus/genetics , West Nile virus/immunology , Young Adult
4.
P R Health Sci J ; 23(2 Suppl): 29-34, 2004 Jun.
Article in English | MEDLINE | ID: mdl-16929584

ABSTRACT

The World Health Organization estimates the world prevalence of viral hepatitis C at 3%. The advent of therapeutic regimens for viral hepatitis has made the liver biopsy a routine specimen in the surgical pathology laboratory. The clinician will need to know the degree and type of necroinflammatory activity and the presence and level of fibrosis, before making the decision to start therapy. The biopsy is essential in determining the nature and extent of hepatic injury, the degree of inflammation, the type of inflammatory reaction, the distribution of fibrosis and the presence of other findings affecting the patient's prognosis. A scoring system is essential in the therapeutic trials for treatment of viral hepatitis and can be helpful in making therapeutic decisions. The aim of this article is to summarize the terminology, histologic findings, the available and more commonly used scoring systems and the surgical report of chronic viral hepatitis C.


Subject(s)
Hepatitis C/pathology , Liver/pathology , Biopsy/methods , Biopsy/standards , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...